Drug intelligence / Profile preview

anti-MUC4-IRDye800CW

Development stage
Preclinical
Lead developer
University of Nebraska Medical Center
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

anti-MUC4-IRDye800CW is a near-infrared (NIR) fluorescently labeled monoclonal antibody developed for the intraoperative detection and localization of Mucin-4 (MUC4) expressing tumors. The agent consists of a monoclonal antibody specific to MUC4, a transmembrane glycoprotein frequently overexpressed in various adenocarcinomas including gastric and pancreatic cancers, conjugated to the NIR fluorophore IRDye800CW. Upon intravenous administration, the antibody selectively binds to MUC4 on the surface of malignant cells, allowing for real-time fluorescence imaging of primary tumors and metastatic lesions, such as peritoneal carcinomatosis. This technology is intended to assist surgeons in achieving complete tumor resection by clearly defining surgical margins and identifying small or occult metastases that are difficult to detect with standard white-light visualization.

Brand names
anti-MUC4-IR800anti-MUC-4-IR800anti-MUC 4-IR800
Other names
anti-mucin-4-antibody conjugated near infrared fluorophoreanti-mucin4-antibody conjugated near infrared fluorophoreanti-mucin 4-antibody conjugated near infrared fluorophoreanti-mucin-4-IRDye800CWanti-mucin4-IRDye800CWanti-mucin 4-IRDye800CW
02

Targets

MUC4 (Mucin-4)

Beyond the preview

Go deeper on anti-MUC4-IRDye800CW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-MUC4-IRDye800CW.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call